Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wakamoto Pharmaceutical CoTSE:4512 63 Days Inventory is 242.13 as of Mar. 2026, which is 31% above its 10-year median of 185.33. GuruFocus rates TSE:4512 with a GF Score™ of 63/100 and a GF Value™ of 円319.10 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 923 Drug Manufacturers companies, Wakamoto Pharmaceutical Co ranks worse than 75.51% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Wakamoto Pharmaceutical Co's Inventory Turnover for the
six
months ended in Mar. 2026 was 0.75.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Wakamoto Pharmaceutical Co's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.67.
Wakamoto Pharmaceutical Co (TSE:4512) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Wakamoto Pharmaceutical Co's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Wakamoto Pharmaceutical Co's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Wakamoto Pharmaceutical Co Days Inventory Related Terms
Wakamoto Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Wakamoto Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wakamoto Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Wakamoto Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Wakamoto Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wakamoto Pharmaceutical Co (TSE:4512) has a Days Inventory of 242.13 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Wakamoto Pharmaceutical Co and its competitors. This is 31% above median its historical median of 185.33. Over the past decade, Wakamoto Pharmaceutical Co's Days Inventory has ranged from 168.53 to 245.77. According to the industry distribution chart, Wakamoto Pharmaceutical Co ranks #697 out of 923 companies in the Drug Manufacturers industry, placing it in the top 75.5%.
Is Wakamoto Pharmaceutical Co's Days Inventory too high?
Wakamoto Pharmaceutical Co's current Days Inventory of 242.13 is 31% above median its 10-year median of 185.33. Over the past 10 years, this metric has ranged from a low of 168.53 to a high of 245.77. The Drug Manufacturers industry median Days Inventory is 164.48. Wakamoto Pharmaceutical Co's value of 242.13 is 47.2% above this industry median. Based on the distribution chart, Wakamoto Pharmaceutical Co ranks #697 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Wakamoto Pharmaceutical Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wakamoto Pharmaceutical Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Wakamoto Pharmaceutical Co ranks #697 out of 923 companies for Days Inventory. This places Wakamoto Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 164.48. Wakamoto Pharmaceutical Co's value of 242.13 is 47.2% above this benchmark. Historically, Wakamoto Pharmaceutical Co's own Days Inventory has ranged from 168.53 to 245.77 over the past decade. While the company's 10-year median is 185.33 vs. the industry median of 164.48, Wakamoto Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wakamoto Pharmaceutical Co's current Days Inventory of 242.13 is 47.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Wakamoto Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wakamoto Pharmaceutical Co's current Days Inventory is 242.13, which is 31% above median its own 10-year median of 185.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wakamoto Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Wakamoto Pharmaceutical Co (TSE:4512) is currently considered Modestly Undervalued. The stock's GF Value™ is 円319.10, compared to a current price of 円278.00 — trading 12.9% below its estimated fair value. The current Days Inventory is 242.13, which is 31% above median its 10-year median of 185.33 and 47.2% above the Drug Manufacturers industry median of 164.48. Wakamoto Pharmaceutical Co's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Wakamoto Pharmaceutical Co (TSE:4512), the current Days Inventory is 242.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wakamoto Pharmaceutical Co (TSE:4512) Overvalued in 2026?
Based on GuruFocus' analysis, Wakamoto Pharmaceutical Co stock appears to be undervalued.
The current stock price of 円278.00 is trading 12.9% below its estimated GF Value™ of 円319.10.
GuruFocus considers Wakamoto Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TSE:4512:
Days Inventory: 242.13 (31% above median its 10-year median of 185.33)
GF Value™: 円319.10 vs. price of 円278.00 (12.9% below fair value)
Industry Position: 47.2% above the Drug Manufacturers median (#697 of 923)
No single metric tells the full story. See the TSE:4512 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wakamoto Pharmaceutical Co Ltd is the pharmaceutical company based in Japan. It is engaged in the research and development, production and sale of ethical drugs and non-prescription drugs. The company specializes in therapeutic and diagnostic agents for ophthalmic disorders. It offers Strong Wakamoto, a gastrointestinal drug for digestion, the intestinal function controlling, and nutritional supply.
63GF Score
Get the complete analysis for TSE:4512
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4512 has been successfully added to your 
